Risk factors and markers of inflammation of comorbid allergic diseases: rhinitis and bronchial asthma

Introduction. Today there has been a steady increase in the allergic pathology of the respiratory tract - bronchial asthma and allergic rhinitis in pediatric practice. Despite the use of modern diagnostic approaches, we cannot say with certainty which combined effect of which factors leads to the development of allergic inflammation of the respiratory tract. The study of risk factors for the formation of allergic rhinitis and asthma in children is necessary for timely early diagnosis with the subsequent development of an individual strategy for preventive measures.

Objective: to study risk factors and markers of allergic inflammation in children with allergic rhinitis, rhinitis and bronchial asthma and only with bronchial asthma.

Materials and methods. The study involved 107 children suffering from allergic rhinitis, allergic rhinitis and bronchial asthma, and only bronchial asthma. All patients underwent clinical, laboratory, functional, allergological examination, analysis of the cellular composition of bronchial and nasal secretions.

Results. The analysis revealed factors influencing the development of bronchial asthma, allergic rhinitis and comorbid diseases, as well as markers of allergic inflammation. There were trends in detecting a higher level of eosinophils in blood, nasal and bronchial secretions in a group of children with a comorbid condition — bronchial asthma and allergic rhinitis.

Conclusion. Evaluation of the level of markers of allergic inflammation of nasal and bronchial secretions can be used as additional criteria for early diagnosis, prediction of the severity of bronchial asthma and allergic rhinitis in children, serve as a monitoring method, development of personalized preventive measures for this group of children.

1. Smirnova MI, Antipushina DN, Kurekhyan AS. Bronchial asthma and allergic rhinitis in the era of COVID-19: publication data from the first spring of the pandemic and expert recommendations Preventive medicine. 2021; 24 (4): 105–112. (In Russ.)]. https://doi.org/10.17116/profmed202124041105.

2. O’Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK. Inhaled combined budesonide-formoterol as needed in mild asthma. The New England Journal of Medicine. 2018 May; 378 (20): 1865–1876.

3. Leshchenko IV, Baranova II. Bronchial asthma: simple solutions of complex issues. Meditsinskiy sovet. 2019; 6: 52–57. (In Russ.)] https://doi.org/10.21518/2079-701X-2019-6-52-57.

4. Yurenko AV, Antonyuk MV, Mineeva EE, Gvozdenko TA. Predictors of small airway dysfunction in bronchial asthma. Therapeutic archive. 2022; 94 (3): 389–395. (In Russ.)] https://doi.org/10.26442/00403660.2022.03.201400.

5. Aisanov ZR, Kalmanova EN. The lesion of small airways in patients with asthma: new data, new paradigm. Practical Pulmonology. 2019; 1: 6–14. (In Russ.)]

6. Ovsyannikov DY, Eliseeva TI, Khaled M, et al. Comorbidity of bronchial asthma in children: causal, complicated, unspecified, reverse. Pediatrics. Journal them. G. N. Speransky. 2021; 100 (2): 127–137. (In Russ.)]

7. Bousquet J, Arnavielhe S, Bedbrook A, Bewick M, Laune D, Mathieu-Dupas E et al. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clin. Transl. Allergy. 2018; 8: 45. DOI: 10.1186/s13601-018-0227-6.

8. Arefieva NA, Aznabaeva LF. Immune reactions of the nasal mucosa: cytological diagnostics, methods of treatment. Consilium Medicum. 2009; 11: 30–33. (In Russ.)]

9. Arefieva NA, Kilsenbaeva FA, Aznabaeva LF, Khafizova FA, Mashko PN. Immunocytological research in rhinology: Textbook. Ufa: Bashkortostan Publishing House, 2005. — 88 p.: ill. 71. (In Russ.)]

10. Mokronosova MA, Kochetova YI. Methodological approaches to the assessment of local inflammation of the nasal cavity. Russian Allergological Journal. 2009; 1: 24–28. (In Russ.)]

11. Faience AA, Ershova VP, Akimova TV. Quantitative criteria for a rhinocytogram of a healthy person. Clinical and laboratory diagnostics. 1996; 2: 13–14. (In Russ.)]

12. Kulichkov VI, Mizernitsky YL, Rybakova OG, Minina EE, Zhakov YI. Pat. RF 2364341 Method for obtaining induced sputum in children to assess the degree and nature of inflammation of the bronchial mucosa. No. 2008116364; dec. 04/24/2008; publ. 20.08.2009, Bull. No. 23. — 10 p. (In Russ.)]

13. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2022. Available at: https://ginasthma.org/gina-reports/

14. National program. Bronchial asthma in children. Treatment strategy and prevention. Coord. Geppe NA, Kolosov NG, Kondyurina EG, et al., 6th ed., revised, and additional. M.: MedKom-Pro, 2022. (In Russ.)]

15. Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines — 2016 Revision. J. Allergy Clin Immunol. 2017; 140 (4): 950–958. https://doi.org/10.1016/j.jaci.2017.03.050.

16. Khaitov MR, Namazova-Baranova LS, Ilyina NI, Kurbacheva OM, S. Bachert, PW Hellings, O Pfaar, HJ Schűnemann, D. Wallace, A. Bedbrook, W. Czarlewski, J. Bousquet. ARIA 2019: Allergic Rhinitis Care Algorithms in Russia. Russian Allergological Journal. 2020; 17(1): 7–22. (In Russ.)] https://doi.org/10.36691/RAJ.2020.17.1.001.